Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAID therapy for temporomandibular joint pain during acrylic denture rehabilitation
ACTRN12624000434594Phase 3Active, not recruiting
- Sponsor
- Srdjan D. Postic
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nimesulide, etofenamate and ketoprofen in temporomandibular disorder (TMD) (3 arms), sponsored by Srdjan D. Postic. Primary endpoints: Change in temporomandibular joint pain and Temporomandibular joint dysfunction by Helkimo dysfunction index. Started Oct 2015; status: active, not recruiting.
02
Drugs
nimesulideetofenamateketoprofen
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on ACTRN12624000434594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000434594.